Insurance AI Agent Orchestration Build vs Buy | Moring
For insurance orchestration, the build-versus-buy decision hinges on governance, not agent quality. Most enterprise agents now come from vendor platforms, and 61 percent of organizations use vendor tools to put AI into workflows. Carriers need to decide which layers they must own: the coordination of core insurance workflows, or the controls around them.
Short answer
For insurance orchestration, the build-versus-buy decision hinges on governance, not agent quality. Most enterprise agents now come from vendor platforms, and 61 percent of organizations use vendor tools to put AI into workflows. Carriers need to decide which layers they must own: the coordination of core insurance workflows, or the controls around them.
How it works
The build-versus-buy question for insurance orchestration is less about whether a carrier can build agents and more about which layer it is willing to own. Most enterprise AI agents now come from someone else's platform. According to the 2026 Global State of IT Automation Report, 61 percent of organizations use AI-vendor tools such as OpenAI Agent Builder, the Claude Agent SDK, and Google Workspace Studio to put AI into their workflows, making vendor platforms the single most common source of agents in the enterprise. A carrier that builds only some of its agents still has to orchestrate all of them.
Building the orchestration layer in-house gives a carrier maximum control over how claims, underwriting, and servicing workflows chain together, and over how context moves between policy administration systems, claims platforms, telematics feeds, and third-party risk data. That control matters because insurance decisions depend on context that is scattered across many systems, and assembling it is where orchestrated workflows earn their value. The cost is engineering permanence: orchestration state management, failure handling, and permission enforcement become products the carrier maintains indefinitely.
Buying an orchestration platform shifts that burden but introduces a different dependency. An AI agent orchestration platform is a control layer for coordinating multiple agents toward a shared goal, and platform evaluations increasingly emphasize enterprise production fitness rather than demo appeal. For a carrier, the evaluation criteria that matter are the governed ones: whether the platform enforces human approval gates for high-risk actions, applies execution limits that prevent runaway costs, and produces a workflow-level trace that compliance can review without engineering help.
Insurance-specific vendors are converging on this middle ground. Agentic platforms for insurers now promise to connect agents with trusted insurance data, business rules, workflows, people, and core systems, and to orchestrate how work moves from intelligence to action. Decisioning vendors are shipping curated catalogs of insurance-specific agents inside governed orchestration systems for pricing, underwriting, and customer decisions. That changes the calculus: for decisioning workflows governed by actuarial review, a purpose-built platform may carry less model risk than a general framework assembled internally.
The regulatory lens sharpens the decision. The EU AI Act imposes risk-based obligations on AI systems, including autonomous agents that plan and execute multi-step action chains, and carriers operating in the European market need evidence of control regardless of who wrote the agent code. Governance obligations travel with the deployer: a carrier cannot outsource accountability for what an orchestrated workflow did by licensing the orchestrator. Whichever route is chosen, the record of every handoff and approval must be retrievable in the carrier's own systems.
A pragmatic pattern emerges from enterprise practice: buy or adopt the platform for commodity coordination, reserve in-house engineering for the insurance-specific context layer and the control plane, and insist that any vendor component export its traces. The worst outcome is the fragmented one, where teams build isolated agents on whatever tool they prefer and the carrier ends up with process gaps, duplicate work, and costs nobody can explain. Deciding the layer boundaries deliberately is what separates an orchestration strategy from an accumulation of pilots.
Whichever direction the decision leans, contract and exit terms deserve as much attention as features. A carrier that buys should secure export of workflow traces in an open format, defined support for permission and approval configuration, and clear terms for what happens to case data if the relationship ends. A carrier that builds should budget for the unglamorous layers, state management, identity, tracing, that make orchestration governable, because those are precisely the layers vendors sell. The decision is revisitable; being locked into an unauditable position is not. Revisit the decision on a defined cadence, because the platform market is moving quickly and the layers a carrier chose to build or buy two years ago may not be the right split today.
Frequently asked questions
Should an insurer build its own orchestration layer or buy one?
Decide by layer, not wholesale. Building gives maximum control over how claims and underwriting workflows chain and how context moves between policy, claims, and telematics systems, but it makes orchestration a product the carrier maintains forever. Buying shifts that burden to a platform. Most carriers land on buying coordination and reserving in-house work for the insurance context layer and control plane.
Why does the build-versus-buy question involve governance so heavily?
Because accountability cannot be outsourced. The EU AI Act imposes risk-based obligations on systems including autonomous multi-step agents, and the deployer remains answerable for what an orchestrated workflow did regardless of who wrote the code. Whichever route a carrier chooses, the record of every handoff and approval must be retrievable in its own systems, and vendor components must export their traces.
How common are vendor-supplied agents in enterprises today?
Very common: the 2026 Global State of IT Automation Report found 61 percent of organizations use AI-vendor tools such as OpenAI Agent Builder, the Claude Agent SDK, and Google Workspace Studio to put AI into their workflows, making vendors the single most common source of agents. A carrier that builds none of its agents still has to orchestrate all of them, which is why the buy side needs governance evaluation.
What evaluation criteria matter most when comparing orchestration platforms for insurance?
Prioritize governed capabilities: runtime enforcement of permissions at each handoff, human approval gates for consequential actions, execution limits that prevent runaway costs, workflow-level tracing that compliance can read without engineering help, and cost attribution per completed case. Insurance-specific platforms add domain fit for pricing and underwriting governance. A platform that only coordinates well but cannot produce evidence will fail an audit regardless of throughput.